Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 2, 1998, Pages 159-166

  Akiyama, Yohko ^a   Nagahara, Naoki ^a   Nara, Eiji ^a   Kitano, Megumi ^a   Iwasa, Susumu ^a   Yamamoto, Isamu ^b   Azuma, Junichi ^b   Ogawa, Yasuaki ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; GELATIN; MICROSPHERE; RIBOFLAVIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DISTRIBUTION; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRANSIT; HUMAN; HUMAN EXPERIMENT; INTESTINE MUCOSA; MALE; MEAN RESIDENCE TIME; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RAT; STOMACH MUCOSA; SUSTAINED RELEASE PREPARATION;

EID: 0031890348     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb06171.x     Document Type: Article

References (20)

1. Akiyama, Y., Horibe, H., Yoshioka, M., Hirai, S., Kitamori, N., Toguchi, H. (1993) Novel oral controlled-release microspheres using polyglycerol esters of fatty acids. J. Contr. Rel. 26: 1-10
2. Akiyama, Y., Nagahara, N., Kashihara, T., Hirai, S., Toguchi, H. (1995) In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly(acrylic acid) derivative. Pharm. Res. 12: 397-405
3. Chungi, V. S., Dittert, L. W., Smith, R. B. (1979) Gastrointestinal sites of furosemide absorption in rats. Int. J. Pharm. 4: 27-38
4. Graul, E. H., Loew, D., Schuster, O. (1985) Voraussetzung für die Entwicklung einer sinnvollen Retard- und Diuretika-kombination Therapiewoche 35: 4277-4291
5. Harris, D., Fell, J. T., Sharma, H. L., Taylor, D. C. ( 1990) GI transit of potential bioadhesive formulations in man: a scintigraphic study. J. Contr. Rel. 12: 45-53
6. Hosny, E. A., El-Sayed, Y. M., Al-Meshal, M. A., Al-Angaryl, C. A. A. (1994) Effect of food on bioavailability of bioadhesive-containing indomethacin tablets in dogs. Int. J. Pharm. 112: 87-91
7. Khosla, L., Davis, S. S. (1987) The effect of polycarbophil on the gastric emptying of pellets. J. Pharm. Pharmacol. 39: 47-49
8. Khosla, R., Feely, L. C., Davis, S. S. (1989) Gastrointestinal transit of non-disintegrating tablets in fed subjects. Int. J. Pharm. 53: 107-117
9. Kimura, K., Ido, K., Saifuku, K., Kihira, K., Satoh, K., Takimoto, T., Yoshida, Y. (1995) A 1-h topical therapy for the treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 90: 60-63
10. Lee, M. G., Chiou, W. L. (1983) Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J. Pharmacokin. Biopharm. 11: 623-640
11. Lehr, C.-M., Boustra, J. A., Tukker, J. J., Junginger, H. E. (1990) Intestinal transit of bioadhesive microspheres in an in situ loop in the rat - a comparable study with copolymers and blends based on poly(acrylic acid). J. Contr. Rel. 13: 51-62
12. Lehr, C.-M., Boustra, J. A., Wouter, K., De Boer, A. G., Tukker, J. J., Verhoef, J. C., Breimer, D. D., Junginger, H. E. (1992) Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat. J. Pharm. Pharmacol. 44: 402-407
13. Lenaerts, V., Couvreur, P., Grislain, L., Maincent, P. (1990) Nanoparticles as a gastroadhesive drug delivery system. In: Lenaerts, V., Gurny, R. (eds) Bioadhesive Drug Delivery Systems. CRC Press, Boca Raton, Florida, pp 95-104
14. Levy, G., Jusko, C. O. (1966) Factors affecting the absorption of riboflavin in man. J. Pharm. Sci. 55: 285-289
15. Longer, M. A., Ch'ng, H. S., Robinson, J. R. (1985) Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. J. Pharm. Sci. 74: 406-411
16. Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., Morrell, C. (1997) Biologically erodable microspheres as potential oral drug delivery systems. Nature 386: 410-414
17. Middleton III. H. M. (1990) Uptake of riboflavin by rat intestinal mucosa in vitro. J. Nutr. 120: 588-593
18. Stripp, B. (1965) Intestinal absorption of riboflavin by man. Acta Pharmacol. Toxicol. 22: 353-362
19. Wilding, I. R., Coupe, A. J., Davis, S. S. (1991) The role of gamma scintigraphy in oral drug delivery. Adv. Drug Del. Rev. 7: 87-117
20. Yamaoka, K., Tamgawara, Y., Uno, T. (1978) Statistical moments in pharmaeokinetics. J. Pharmacokin. Biopharm. 6: 547-558